142 related articles for article (PubMed ID: 1037483)
1. Clinical studies with bromocriptine in idiopathic parkinsonism.
Teychenne PF; Kartzinel R; Perlow M; Pfeiffer R; Calne DB
Trans Am Neurol Assoc; 1976; 101():302-4. PubMed ID: 1037483
[No Abstract] [Full Text] [Related]
2. [Treatment of Parkinson's disease with bromocriptine].
Castaigne P; Laplane D; Bousser MG; Bories F
Nouv Presse Med; 1976 Apr; 6(17):1482. PubMed ID: 1037400
[No Abstract] [Full Text] [Related]
3. [Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
Kissel P; Andre JM; Jacquier A
Nouv Presse Med; 1976 Jan; 5(4):210. PubMed ID: 1264671
[No Abstract] [Full Text] [Related]
4. Developments in the treatment of parkinsonism.
Calne DB
N Engl J Med; 1976 Dec; 295(25):1433-4. PubMed ID: 989886
[No Abstract] [Full Text] [Related]
5. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
Kartzinel R; Perlow MD; Carter AC; Chase TN; Calne DB; Shoulson I
Trans Am Neurol Assoc; 1976; 101():53-6. PubMed ID: 141763
[No Abstract] [Full Text] [Related]
6. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Kartzinel R; Shoulson I; Calne DB
Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655
[TBL] [Abstract][Full Text] [Related]
7. Letter: Bromocriptine in parkinsonism.
Debono AG; Donaldson I; Marsden CD; Parkes JD
Lancet; 1975 Nov; 2(7942):987-8. PubMed ID: 53479
[No Abstract] [Full Text] [Related]
8. Studies with bromocriptine. Part 1. "On-off" phenomena.
Kartznel R; Calne DB
Neurology; 1976 Jun; 26(6 PT 1):508-10. PubMed ID: 945489
[TBL] [Abstract][Full Text] [Related]
9. [Letter: Effect of bromocryptine on the fluctuations following dopa therapy. On-off phenomenon in parkinsonian patients].
Frattola L; Albizzati MG; Spano PF; Trabucchi M
Nouv Presse Med; 1976 Aug 28-Sep 4; 5(28):1761. PubMed ID: 958891
[No Abstract] [Full Text] [Related]
10. [Treatment of parkinsonism with dopaminergic system agonists].
Dowzenko A
Neurol Neurochir Pol; 1976; 10(4):579-82. PubMed ID: 958587
[No Abstract] [Full Text] [Related]
11. [Clinical experience with bromocriptine, a central dopaminergic stimulator].
Ludin HP; Kunz F; Lörincz P; Ringwald E
Nervenarzt; 1976 Nov; 47(11):651-5. PubMed ID: 794749
[No Abstract] [Full Text] [Related]
12. Letter: Bromocriptine in parkinsonism.
Lees AJ; Shaw KM; Stern GM
Lancet; 1975 Oct; 2(7937):709-10. PubMed ID: 52084
[No Abstract] [Full Text] [Related]
13. An ergot derivative in the treatment of Parkinson's disease.
Calne DB; Shoulson I; Kartzinel R
Postgrad Med J; 1976; 52suppl 1():81-5. PubMed ID: 183198
[No Abstract] [Full Text] [Related]
14. Treatment of parkinsonism with bromocriptine.
Calne DB; Teychenne PF; Leigh PN; Bamji AN; Greenacre JK
Lancet; 1974 Dec; 2(7893):1355-6. PubMed ID: 4143315
[No Abstract] [Full Text] [Related]
15. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
Serby M; Angrist B; Lieberman A
Adv Biochem Psychopharmacol; 1980; 23():287-92. PubMed ID: 6104908
[No Abstract] [Full Text] [Related]
16. Ergot derivatives for Parkinsonism.
Calne DB; Williams AC; Nutt JG; Neophytides A; Eisler T; Teychenne PF
Med J Aust; 1978 Nov; 2(3 Suppl):25-6. PubMed ID: 34083
[TBL] [Abstract][Full Text] [Related]
17. Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
LeWitt PA; Burns RS; Calne DB
Adv Neurol; 1983; 37():131-40. PubMed ID: 6344586
[TBL] [Abstract][Full Text] [Related]
18. Role of ergot derivatives in the treatment of parkinsonism.
Calne DB
Fed Proc; 1978 Jun; 37(8):2207-9. PubMed ID: 658459
[No Abstract] [Full Text] [Related]
19. [Bromocriptine and Parkinson's disease: initial results].
Petit H; Destee A
Lille Med; 1977; 22(6):362-5. PubMed ID: 578286
[No Abstract] [Full Text] [Related]
20. Bromocriptine in the treatment of parkinsonism.
Parkes JD
Drugs; 1979 May; 17(5):365-82. PubMed ID: 37066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
